Business
Politics
Stocks
Investing

Business
Politics
Stocks
Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin June 4, 2025

June 4, 2025

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

previous post

Operational Update

next post

Mali Court Adjourns Barrick’s Gold Complex Hearing Over Deepening Taxes, Control Dispute

Related Posts

Lithium Universe LtdSpodumene Offtake Update

June 2, 2025

Victoria Gold-Silver Exploration Update

June 5, 2025

CHARBONE Hydrogen Executed a USD 50MM Financing to...

June 5, 2025

Canadian Wildfires Force Mining Sector to Retreat as...

June 3, 2025

Scoping Study Demonstrates Low Cost Potential (Replacement)

June 5, 2025

Crypto Market Recap: Circle Targets US$7.2 Billion IPO,...

June 3, 2025

Auto Industry Takes Hit as China’s Rare Earths...

June 6, 2025

Bird Flu Vaccine Stocks: 8 Companies Developing H5N1...

June 4, 2025

Editor’s Picks: Marathon Project Gets Nod, Rio Tinto...

June 7, 2025

Triumph Gold Announces the Acquisition of the Coyote...

June 4, 2025

Recent

Silver’s Surge is No Fluke—Here’s the Strange Ratio Driving It
Everyone Talks About Leaving a Better Planet for Our Children: Why Don’t We Leave Better Children for Our Planet?
Big Rally Ahead Should Yield All-Time High on This Index
Your Weekly Stock Market Snapshot: What It Means for Your Investments
From Tariffs to Tech: Where Smart Money’s Moving Right Now
Week Ahead: NIFTY’s Behavior Against This Level Crucial As The Index Looks At Potential Resumption Of An Upmove

Categories

Business (23)
Investing (59)
Politics (60)
Stocks (26)

About us
Contact us
Privacy Policy
Terms & Conditions

Copyright © 2025 redwoodinvestreport.com | All Rights Reserved